Interleukin-34 sustains inflammatory pathways in the gut

Clinical Science

Volumn 129, Issue 3, 2015, Pages 271-280

  Franzé, Eleonora ^a   Monteleone, Ivan ^a   Cupi, Maria Laura ^a   Mancia, Pamela ^a   Caprioli, Flavio ^b   Marafini, Irene ^a   Colantoni, Alfredo ^a   Ortenzi, Angela ^a   Laudisi, Federica ^a   Sica, Giuseppe ^a   Sileri, PierPaolo ^a   Pallone, Francesco ^a   Monteleone, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Crohn's disease; Cytokines; Immunity; Intestine; Mucosal inflammation; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; INTERLEUKIN 34; INTERLEUKIN 6; MESALAZINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STEROID; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN DERIVATIVE; INTERLEUKIN-34, HUMAN;

ARTICLE; CELL INFILTRATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; INTESTINE BIOPSY; LAMINA PROPRIA; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULUS RESPONSE; ULCERATIVE COLITIS; UPREGULATION; ENTEROENDOCRINE CELL; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; SIGNAL TRANSDUCTION;

COLITIS, ULCERATIVE; CROHN DISEASE; ENTEROENDOCRINE CELLS; HUMANS; INFLAMMATION; INTERLEUKINS; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84937511452     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150132     Document Type: Article

References (41)

1. Xavier, R.J. and Podolsky, D.K. (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434.
2. Abraham, C. and Cho, J.H. (2009) Inflammatory bowel disease. N. Engl. J. Med. 361, 2066-2078.
3. Kaser, A., Zeissig, S. and Blumberg, R.S. (2010) Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573-621.
4. MacDonald, T.T. and Spencer, J. (1988) Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J. Exp. Med. 167, 1341-1349.
5. Brandtzaeg, P., Carlsen, H.S. and Halstensen, T.S. (2006) The B-cell system in inflammatory bowel disease. Adv. Exp. Med. Biol. 579, 149-167.
6. Middendorp, S. and Nieuwenhuis, E.E. (2009) NKT cells in mucosal immunity. Mucosal Immunol. 2, 393-402.
7. Rugtveit, J., Brandtzaeg, P., Halstensen, T.S., Fausa, O. and Scott, H. (1994) Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 35, 669-674.
8. Strober, W. and Fuss, I.J. (2011) Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1756-1767.
9. Sandborn, W.J., van Assche, G., Reinisch, W., Colombel, J.F., D'Haens, G., Wolf, D.C., Kron, M., Tighe, M.B., Lazar, A. and Thakkar, R.B. (2012) Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology 142, 257-265.
10. Targan, S.R., Hanauer, S.B., van Deventer, S.J., Mayer, L., Present, D.H., Braakman, T., DeWoody, K.L., Schaible, T.F. and Rutgeerts, P.J. (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group. N. Engl. J. Med. 337, 1029-1035.
11. Lin, H., Lee, E., Hestir, K., Leo, C., Huang, M., Bosch, E., Halenbeck, R., Wu, G., Zhou, A., Behrens, D. et al. (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320, 807-811.
12. Baud'huin, M., Renault, R., Charrier, C., Riet, A., Moreau, A., Brion, R., Gouin, F., Duplomb, L. and Heymann, D. (2010) Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J. Pathol. 221, 77-86.
13. Greter, M., Lelios, I., Pelczar, P., Hoeffel, G., Price, J., Leboeuf, M., Kundig, T.M., Frei, K., Ginhoux, F., Merad, M. and Becher, B. (2012) Stroma-derived interleukin-34 controls the development and maintenance of Langerhans cells and the maintenance of microglia. Immunity 37, 1050-1060.
14. Wang, Y., Szretter, K.J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A.D., Diamond, M.S. and Colonna, M. (2012) IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13, 753-760.
15. Preisser, L., Miot, C., Le Guillou-Guillemette, H., Beaumont, E., Foucher, E.D., Garo, E., Blanchard, S., Fremaux, I., Croue, A., Fouchard, I. et al. (2014) IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells. Hepatology 60, 1879-1890.
16. Byrne, P.V., Guilbert, L.J. and Stanley, E.R. (1981) Distribution of cells bearing receptors for a colony-stimulating factor (CSF-1) in murine tissues. J. Cell Biol. 91, 848-853.
17. Ma, X., Lin, W.Y., Chen, Y., Stawicki, S., Mukhyala, K., Wu, Y., Martin, F., Bazan, J.F. and Starovasnik, M.A. (2012) Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R. Structure 20, 676-687.
18. Wei, S., Nandi, S., Chitu, V., Yeung, Y.G., Yu, W., Huang, M., Williams, L.T., Lin, H. and Stanley, E.R. (2010) Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J. Leukoc. Biol. 88, 495-505.
19. Chihara, T., Suzu, S., Hassan, R., Chutiwitoonchai, N., Hiyoshi, M., Motoyoshi, K., Kimura, F. and Okada, S. (2010) IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ. 17, 1917-1927.
20. Eda, H., Shimada, H., Beidler, D.R. and Monahan, J.B. (2011) Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK-and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts. Rheumatol. Int. 31, 1525-1530.
21. Chemel, M., Le Goff, B., Brion, R., Cozic, C., Berreur, M., Amiaud, J., Bougras, G., Touchais, S., Blanchard, F., Heymann, M.F. et al. (2012) Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann. Rheum. Dis. 71, 150-154.
22. Hwang, S.J., Choi, B., Kang, S.S., Chang, J.H., Kim, Y.G., Chung, Y.H., Sohn, D.H., So, M.W., Lee, C.K., Robinson, W.H. and Chang, E.J. (2012) Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Res. Ther. 14, R14.
23. Li, Z., Jin, D., Wu, Y., Zhang, K., Hu, P., Cao, X. and Chen, Z. (2012) Increased serum interleukin-34 in patients with coronary artery disease. J. Int. Med. Res. 40, 1866-1870.
24. Ciccia, F., Alessandro, R., Rodolico, V., Guggino, G., Raimondo, S., Guarnotta, C., Giardina, A., Sireci, G., Campisi, G., De Leo, G. and Triolo, G. (2013) IL-34 is overexpressed in the inflamed salivary glands of patients with Sjögren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes. Rheumatology 52, 1009-1017.
25. Klebl, F.H., Olsen, J.E., Jain, S. and Doe, W.F. (2001) Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine. J. Pathol. 195, 609-615.
26. Marshall, D., Cameron, J., Lightwood, D. and Lawson, A.D. (2007) Blockade of colony stimulating factor-1 (CSF-I) leads to inhibition of DSS-induced colitis. Inflamm. Bowel Dis. 13, 219-224.
27. Foucher, E.D., Blanchard, S., Preisser, L., Garo, E., Ifrah, N., Guardiola, P., Delneste, Y. and Jeannin, P. (2013) IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNγ. PLoS ONE 8, e56045.
28. Monteleone, G., Biancone, L., Marasco, R., Morrone, G., Marasco, O., Luzza, F. and Pallone, F. (1997) Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112, 1169-1178.
29. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T. and Saltiel, A.R. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
30. Monteleone, G., Kumberova, A., Croft, N.M., McKenzie, C., Steer, H.W. and MacDonald, T.T. (2001) Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J. Clin. Invest. 108, 601-609.
31. Strober, W., Fuss, I. and Mannon, P. (2007) The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 117, 514-521.
32. Wang, T., Kono, T., Monte, M.M., Kuse, H., Costa, M.M., Korenaga, H., Maehr, T., Husain, M., Sakai, M. and Secombes, C.J. (2013) Identification of IL-34 in teleost fish: differential expression of rainbow trout IL-34, MCSF1 and MCSF2, ligands of the MCSF receptor. Mol. Immunol. 53, 398-409.
33. Reinecker, H.C., Steffen, M., Witthoeft, T., Pflueger, I., Schreiber, S., MacDermott, R.P. and Raedler, A. (1993) Enhanced secretion of tumour necrosis factor-α, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94, 174-181.
34. Plevy, S.E., Landers, C.J., Prehn, J., Carramanzana, N.M., Deem, R.L., Shealy, D. and Targan, S.R. (1997) A role for TNF-α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J. Immunol. 159, 6276-6282.
35. 2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC). Clin. Exp. Immunol. 117, 469-475.
36. Coskun, M., Olsen, J., Seidelin, J.B. and Nielsen, O.H. (2011) MAP kinases in inflammatory bowel disease. Clin. Chim. Acta 412, 513-520.
37. Atreya, I., Atreya, R. and Neurath, M.F. (2008) NF-κB in inflammatory bowel disease. J. Intern. Med. 263, 591-596.
38. Hoffmann, E., Dittrich-Breiholz, O., Holtmann, H. and Kracht, M. (2002) Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 72, 847-855.
39. Oltmanns, U., Issa, R., Sukkar, M.B., John, M. and Chung, K.F. (2003) Role of c-Jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells. Br. J. Pharmacol. 139, 1228-1234.
40. Chang, S.H., Choi, B.Y., Choi, J., Yoo, J.J., Ha, Y.J., Cho, H.J., Kang, E.H., Song, Y.W. and Lee, Y.J. (2015) Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis. Rheumatol. Int. 35, 71-79.
41. Chang, E.J., Lee, S.K., Song, Y.S., Jang, Y.J., Park, H.S., Hong, J.P., Ko, A.R., Kim, D.Y., Kim, J.H., Lee, Y.J. and Heo, Y.S. (2014) IL-34 is associated with obesity, chronic inflammation, and insulin resistance. J. Clin. Endocrinol. Metab. 99, E1263-E1271.